Skip to Content

PARLODEL 2 1/2 017 017 (Bromocriptine Mesylate 2.5 mg)

Pill with imprint PARLODEL 2 1/2 017 017 is White, Round and has been identified as Bromocriptine mesylate 2.5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..

Bromocriptine is used in the treatment of diabetes, type 2; acromegaly; hyperprolactinemia; parkinson's disease; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PARLODEL 2 1/2 017 017

Bromocriptine mesylate

PARLODEL 2 1/2 017 017
2.5 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Prolactin inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.